Teng Zhou

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).

Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 04, 2026

Correction: Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer.

Correction: Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer.

Journal: Genes and immunity

Published: February 10, 2026

AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies.

AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies.

Journal: Oncogene

Published: February 02, 2026

Pharmacologic Modulation of ARID3A with Rimegepant Reactivates Type I Interferon Signaling and Sensitizes Triple-Negative Breast Cancer to PD-1 Blockade.

Pharmacologic Modulation of ARID3A with Rimegepant Reactivates Type I Interferon Signaling and Sensitizes Triple-Negative Breast Cancer to PD-1 Blockade.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 28, 2025

Complex I protein NDUFB9 is a metabolic vulnerability in triple negative breast cancer brain metastases.

Complex I protein NDUFB9 is a metabolic vulnerability in triple negative breast cancer brain metastases.

Journal: Nature communications

Published: October 03, 2025

Prodigiosin inhibits proliferation and metastasis in head and neck squamous cell carcinoma: insights from phenotypic validation and network pharmacology.

Prodigiosin inhibits proliferation and metastasis in head and neck squamous cell carcinoma: insights from phenotypic validation and network pharmacology.

Journal: Bioorganic chemistry

Published: July 15, 2025

Efficacy of Trastuzumab Deruxtecan in HER2-Positive and HER2-Low Metastatic Breast Cancer: A Real-World Retrospective Cohort Study in China.

Efficacy of Trastuzumab Deruxtecan in HER2-Positive and HER2-Low Metastatic Breast Cancer: A Real-World Retrospective Cohort Study in China.

Journal: Breast cancer (Dove Medical Press)

Published: June 11, 2025

Association of gut microbiota dietary index with MAFLD and the risk of liver fibrosis: the mediating effect of vitamins.

Association of gut microbiota dietary index with MAFLD and the risk of liver fibrosis: the mediating effect of vitamins.

Journal: Journal of nutritional science

Published: April 22, 2025

Astrocyte involvement in brain metastasis: from biological mechanisms to therapeutic strategies.

Astrocyte involvement in brain metastasis: from biological mechanisms to therapeutic strategies.

Journal: Cancer metastasis reviews

Published: February 09, 2025

Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer.

Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer.

Journal: Genes and immunity

Published: December 15, 2024

Overcoming matrix barriers for enhanced immune infiltration using siRNA-coated metal-organic frameworks.

Overcoming matrix barriers for enhanced immune infiltration using siRNA-coated metal-organic frameworks.

Journal: Acta biomaterialia

Published: October 21, 2024

Circadian rhythms and breast cancer: from molecular level to therapeutic advancements.

Circadian rhythms and breast cancer: from molecular level to therapeutic advancements.

Journal: Journal of cancer research and clinical oncology

Published: June 25, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026